Drug Database
Back to search

Poland· PL-100296010

Inventum

A sildenafil product containing sildenafilum, registered in Poland by Aflofarm Farmacja Polska Sp. z o.o.. The same ATC class is registered in 14 of our 19 countries.

ATC G04BE03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedInventumATCG04BE03REGISTER NO.PL-100296010PACKS LISTED6CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about sildenafilumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Sildenafil is registered in 14 of 19 countries.

Countries holding a registration under ATC G04BE03 (sildenafil), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search sildenafil products by name

Sildenafil · ATC G04BE03

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sildenafil costs, country by country.

Normalised to the WHO defined daily dose (50 mg), the median price runs from $0.13 in United States to $21.46 in Italy — a ×168 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Sildenafil · price per daily dose (50 mg)

USD · FX 28 Sept 2026

  • IT Italy$21.46
  • CH Switzerland$13.08
  • US United States$0.13 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Sildenafilum
Manufacturer
Aflofarm Farmacja Polska Sp. z o.o.
Country
Poland (PL)
ATC code
G04BE03
ATC class
Sildenafil
Defined daily dose
50 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 6

  • gtin
    05909991050979
  • gtin
    05909991050986
  • gtin
    05909991050993
  • gtin
    05909991051006
  • gtin
    05906071008981
  • gtin
    05902802703859

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

399 interactions on record for sildenafil.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check sildenafil against other medicinesHow interaction checks work

Sildenafil · interactions on record

399 records

  • 11 severe
  • 118 moderate
  • 4 minor
  • 145 info

Most severe, free to view

  • KetoconazoleH02CA03severe
  • ErythromycinJ01FA01severe
  • ClarithromycinJ01FA09severe
  • KetoconazoleJ02AB02severe

121 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under G04BE03

Sildenafil, as other registers publish it.

All sildenafil products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ac7ea097-42be-4b66-966f-fb4eccdc2088
GET /v1/drugs/ac7ea097-42be-4b66-966f-fb4eccdc2088?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki do rozgryzania i żucia",
  "source": "urpl",
  "strength": "25 mg",
  "packaging": "05909991050979 ¦ OTC ¦ 63826\n2 tabl.\n05909991050986 ¦ OTC ¦ Skasowane ¦ 63827\n4 tabl.\n05909991050993 ¦ OTC ¦ Skasowane ¦ 63828\n8 tabl.\n05909991051006 ¦ OTC ¦ Skasowane ¦ 63829\n12 tabl.\n05906071008981 ¦ OTC ¦ 121535\n4 tabl.\n05902802703859 ¦ OTC ¦ 136930\n8 tabl.",
  "substance": "Sildenafilum 25 mg + Sildenafili citras (tworzony in situ z syldenafilu cytrynianu) 25 mg",
  "common_name": "Sildenafilum",
  "pl_product_id": "100296010",
  "pozwolenie_nr": "21009",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about sildenafil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console